Tabunda, Argie, Jr. N.

HRN: 27-13-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
CEFTRIAXONE 1G (VIAL)
07/04/2025
07/11/2025
IVT
1g
Q12
T/C Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  EmpiricEmpirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: